|
11BE
HIV-1 Rev Filament
Deposited 2026-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 155
PDB declaration: 155-meric
|
Chain A1
1–116(116 aa)
Chain A4
1–116(116 aa)
Chain A5
1–116(116 aa)
Chain A9
1–116(116 aa)
Chain B1
1–116(116 aa)
Chain B4
1–116(116 aa)
Chain B5
1–116(116 aa)
Chain B9
1–116(116 aa)
Chain C1
1–116(116 aa)
Chain C5
1–116(116 aa)
Chain C6
1–116(116 aa)
Chain C9
1–116(116 aa)
Chain D1
1–116(116 aa)
Chain D5
1–116(116 aa)
Chain D6
1–116(116 aa)
Chain D9
1–116(116 aa)
Chain E1
1–116(116 aa)
Chain E5
1–116(116 aa)
Chain E6
1–116(116 aa)
Chain E9
1–116(116 aa)
Chain F1
1–116(116 aa)
Chain F5
1–116(116 aa)
Chain F6
1–116(116 aa)
Chain F9
1–116(116 aa)
Chain G1
1–116(116 aa)
Chain G5
1–116(116 aa)
Chain G6
1–116(116 aa)
Chain G9
1–116(116 aa)
Chain H1
1–116(116 aa)
Chain H5
1–116(116 aa)
Chain H6
1–116(116 aa)
Chain H9
1–116(116 aa)
Chain I1
1–116(116 aa)
Chain I4
1–116(116 aa)
Chain I9
1–116(116 aa)
Chain J1
1–116(116 aa)
Chain J4
1–116(116 aa)
Chain J9
1–116(116 aa)
Chain K1
1–116(116 aa)
Chain K4
1–116(116 aa)
Chain K9
1–116(116 aa)
Chain L1
1–116(116 aa)
Chain L4
1–116(116 aa)
Chain L9
1–116(116 aa)
Chain M1
1–116(116 aa)
Chain M4
1–116(116 aa)
Chain M5
1–116(116 aa)
Chain M9
1–116(116 aa)
Chain N1
1–116(116 aa)
Chain N4
1–116(116 aa)
Chain N5
1–116(116 aa)
Chain N9
1–116(116 aa)
Chain O1
1–116(116 aa)
Chain O4
1–116(116 aa)
Chain O5
1–116(116 aa)
Chain O9
1–116(116 aa)
Chain P1
1–116(116 aa)
Chain P5
1–116(116 aa)
Chain P9
1–116(116 aa)
Chain R1
1–116(116 aa)
Chain R4
1–116(116 aa)
Chain R9
1–116(116 aa)
Chain S1
1–116(116 aa)
Chain S4
1–116(116 aa)
Chain S9
1–116(116 aa)
Chain T1
1–116(116 aa)
Chain T4
1–116(116 aa)
Chain T5
1–116(116 aa)
Chain T9
1–116(116 aa)
Chain U1
1–116(116 aa)
Chain U4
1–116(116 aa)
Chain U5
1–116(116 aa)
Chain U9
1–116(116 aa)
Chain V1
1–116(116 aa)
Chain V5
1–116(116 aa)
Chain V6
1–116(116 aa)
Chain V9
1–116(116 aa)
Chain W1
1–116(116 aa)
Chain W5
1–116(116 aa)
Chain W6
1–116(116 aa)
Chain W9
1–116(116 aa)
Chain X1
1–116(116 aa)
Chain X5
1–116(116 aa)
Chain X6
1–116(116 aa)
Chain X9
1–116(116 aa)
Chain Y1
1–116(116 aa)
Chain Y5
1–116(116 aa)
Chain Y6
1–116(116 aa)
Chain Y9
1–116(116 aa)
Chain a3
1–116(116 aa)
Chain a7
1–116(116 aa)
Chain a8
1–116(116 aa)
Chain b3
1–116(116 aa)
Chain b7
1–116(116 aa)
Chain b8
1–116(116 aa)
Chain c2
1–116(116 aa)
Chain c7
1–116(116 aa)
Chain c8
1–116(116 aa)
Chain d2
1–116(116 aa)
Chain d7
1–116(116 aa)
Chain d8
1–116(116 aa)
Chain e2
1–116(116 aa)
Chain e7
1–116(116 aa)
Chain e8
1–116(116 aa)
Chain f2
1–116(116 aa)
Chain f7
1–116(116 aa)
Chain f8
1–116(116 aa)
Chain g2
1–116(116 aa)
Chain g7
1–116(116 aa)
Chain g8
1–116(116 aa)
Chain h2
1–116(116 aa)
Chain h7
1–116(116 aa)
Chain h8
1–116(116 aa)
Chain i3
1–116(116 aa)
Chain i7
1–116(116 aa)
Chain j3
1–116(116 aa)
Chain j7
1–116(116 aa)
Chain k3
1–116(116 aa)
Chain k7
1–116(116 aa)
Chain l3
1–116(116 aa)
Chain l7
1–116(116 aa)
Chain m3
1–116(116 aa)
Chain m7
1–116(116 aa)
Chain m8
1–116(116 aa)
Chain n3
1–116(116 aa)
Chain n7
1–116(116 aa)
Chain n8
1–116(116 aa)
Chain o3
1–116(116 aa)
Chain o7
1–116(116 aa)
Chain o8
1–116(116 aa)
Chain p3
1–116(116 aa)
Chain p7
1–116(116 aa)
Chain p8
1–116(116 aa)
Chain r3
1–116(116 aa)
Chain r7
1–116(116 aa)
Chain s3
1–116(116 aa)
Chain s7
1–116(116 aa)
Chain t3
1–116(116 aa)
Chain t7
1–116(116 aa)
Chain t8
1–116(116 aa)
Chain u3
1–116(116 aa)
Chain u7
1–116(116 aa)
Chain u8
1–116(116 aa)
Chain v2
1–116(116 aa)
Chain v7
1–116(116 aa)
Chain v8
1–116(116 aa)
Chain w2
1–116(116 aa)
Chain w7
1–116(116 aa)
Chain w8
1–116(116 aa)
Chain x2
1–116(116 aa)
Chain x7
1–116(116 aa)
Chain x8
1–116(116 aa)
Chain y2
1–116(116 aa)
Chain y7
1–116(116 aa)
Chain y8
1–116(116 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 8.30 Å
|
|
5DHV
HIV-1 Rev NTD dimers with variable crossing angles
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain N
1–65(65 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals of scFv-Rev were initially grown in 20% PEG 3350, a variety of salts (200 mM sodium sulfate, sodium bromide, or ammonium phosphate dibasic), and pH ranging from 6.5-8.5.
|
Resolution 2.30 Å
R-free 0.227
|
|
5DHV
HIV-1 Rev NTD dimers with variable crossing angles
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain M
1–65(65 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals of scFv-Rev were initially grown in 20% PEG 3350, a variety of salts (200 mM sodium sulfate, sodium bromide, or ammonium phosphate dibasic), and pH ranging from 6.5-8.5.
|
Resolution 2.30 Å
R-free 0.227
|
|
5DHY
HIV-1 Rev NTD dimers with variable crossing angles
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–65(65 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals of scFv-Rev were initially grown in 20% PEG 3350, a variety of salts (200 mM sodium sulfate, sodium bromide, or ammonium phosphate dibasic), and pH ranging from 6.5-8.5
|
Resolution 3.10 Å
R-free 0.300
|
|
5DHY
HIV-1 Rev NTD dimers with variable crossing angles
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain M
1–65(65 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals of scFv-Rev were initially grown in 20% PEG 3350, a variety of salts (200 mM sodium sulfate, sodium bromide, or ammonium phosphate dibasic), and pH ranging from 6.5-8.5
|
Resolution 3.10 Å
R-free 0.300
|
|
5DHZ
HIV-1 Rev NTD dimers with variable crossing angles
Deposited 2015-08-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain M
1–65(65 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;Crystals of scFv-Rev were initially grown in 20% PEG 3350, a variety of salts (200 mM sodium sulfate, sodium bromide, or ammonium phosphate dibasic), and pH ranging from 6.5-8.5
|
Resolution 4.30 Å
R-free 0.324
|
|
6BSY
HIV-1 Rev assembly domain (residues 1-69)
Deposited 2017-12-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–70(70 aa)
Fragment:assembly domain (UNP residues 1-70)
Chain B
1–70(70 aa)
Fragment:assembly domain (UNP residues 1-70)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;283.15 K;0.1 M sodium citrate, 25% MPD
|
Resolution 2.25 Å
R-free 0.260
|
|
6CF2
Crystal structure of HIV-1 Rev (residues 1-93)-RNA aptamer complex
Deposited 2018-02-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–RNA
Heteromer;Protein × 3
PDB declaration: tetrameric
|
Chain F
1–93(93 aa)
Fragment:UNP residues 1-93
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;291.15 K;2% v/v 1,4-dioxane, 0.1 M Tris, pH 8.0, 15% w/v PEG3350
|
Resolution 3.00 Å
R-free 0.241
|